Pharmacology
Relevant Content
Letter by Zhang and Lai Regarding Article, “A Nationwide Factorial Randomized Trial of Electronic Nudges to Patients With Chronic Kidney Disease and Their General Practices for Increasing Guideline-Directed Medical Therapy: The NUDGE-CKD Trial”
Circulation, Volume 153, Issue 10, Page e910-e910, March 10, 2026.
Genotype-Guided P2Y12-Inhibitor De-Escalation Strategy in Acute Coronary Syndrome: Observational Evidence From the POPular-GUIDE PCI
Circulation: Cardiovascular Interventions, Ahead of Print.
BACKGROUND...
Malnutrition and Cachexia in Inpatients With Acute Cardiac Conditions
BACKGROUND...
Malnutrition is common yet underrecognized in patients with cardiovascular...
Reno-Protective Effects of SGLT2 Inhibitors in Patients With Diabetes Undergoing Percutaneous Coronary Intervention: Insights From the BMC2 Registry
Circulation: Cardiovascular Interventions, Ahead of Print.
BACKGROUND...
2026 Heart Disease and Stroke Statistics
BACKGROUND...
AHA and NIH’s 2026 Statistics Update delivers the latest U.S. data on hear...
Letter by Zhao Regarding Article, “Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial”
Circulation, Volume 153, Issue 2, Page e8-e9, January 13, 2026.
Degree of Cyclooxygenase-2 Inhibition Modulates Blood Pressure Response
Hypertension, Ahead of Print.
BACKGROUND:Large clinical trials compar...
Key Patient Messages: 2025 Acute Coronary Syndromes Guideline
BACKGROUND:Large clinical trials compar...
When the blood flow to the heart is suddenly slowed or stopped this is cal...
State of the Art: Evaluation and Medical Management of Nonobstructive Coronary Artery Disease in Patients With Chest Pain
Non-obstructive coronary artery disease (NOCA) is common, carries signific...
Pragmatic Approaches to the Evaluation and Monitoring of Artificial Intelligence in Healthcare
AHA advisory outlines risk-based governance and continuous monitoring for...
